Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

600 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A

NCT02994407

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Orlando, Florida, United States
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
  • Novo Nordisk Investigational Site East Lansing, Michigan, United States
  • Novo Nordisk Investigational Site Cleveland, Ohio, United States
View all 19 locations
View Trial Details
Completed

The Second Multicenter Hemophilia Cohort Study

NCT00341705

Conditions
Acquired Immunodeficiency Syndrome, Adenocarcinoma, Blood Coagulation Disorders, +46 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • University of California, Davis Davis, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 48 locations
View Trial Details
Completed

PF-06741086 Multiple Dose Study in Severe Hemophilia

NCT02974855

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • UC Denver Hemophilia and Thrombosis Center - Pharmacy Aurora, Colorado, United States
  • UC Denver Hemophilia and Thrombosis Center Aurora, Colorado, United States
  • Pharmacy Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

NCT03660774

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Orange, California, United States
  • Novo Nordisk Investigational Site San Diego, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

NCT00989196

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • UCLA Orthodpedic Hospital Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • University of Colorado Denver, Colorado, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View Trial Details

Related conditions